(Q70644714)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6489416%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

title

Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6489416%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

author name string

A Küpfer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6489416%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

R Preisig

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6489416%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

publication date

1 January 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6489416%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

12 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6489416%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6489416%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

page(s)

753-759

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6489416%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6489416%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00541938

12 October 2019

exact match

0 references

cites work

Defective N-oxidation of sparteine in man: A new pharmacogenetic defect

1 reference

12 December 2020

Polymorphic oxidation of sparteine and debrisoquine: Related pharmacogenetic entities

1 reference

12 December 2020

Stereoselectivity of the arene epoxide pathway of mephenytoin hydroxylation in man.

1 reference

12 December 2020

Clinical pharmacology. Possible clinical importance of genetic differences in drug metabolism

1 reference

12 December 2020

Inheritance of phenytoin hypometabolism: a kinetic study of one family

1 reference

12 December 2020

Monogenic control of variations in antipyrine metabolite formation. New polymorphism of hepatic drug oxidation

1 reference

12 December 2020

The metabolic conversion of 3-methyl-5-ethyl-5-phenyl hydantoin (mesantoin) and of 5-ethyl-5-phenyl hydantoin (nirvanol) to 5 - ethyl -5- (p-hydroxyphenyl) hydantoin

1 reference

12 December 2020

Impairment of phenytoin parahydroxylation as a cause of severe intoxication

1 reference

12 December 2020

Polymorphisms of Oxidation at Carbon Centers of Drugs and Their Clinical Significance

1 reference

12 December 2020

Animal modelling of human polymorphic drug oxidation—the metabolism of debrisoquine and phenacetin in rat inbred strains

1 reference

12 December 2020

Ethnic differences in drug metabolism

1 reference

12 December 2020

Defective oxidation of drugs: pharmacokinetic and therapeutic implications

1 reference

12 December 2020

Stereoselective metabolism and disposition of the enantiomers of mephenytoin during chronic oral administration of the racemic drug in man

1 reference

12 December 2020

Acute intoxication with 5,5-diphenylhydantoin (Dilantin) associated with impairment of biotransformation. Plasma levels and urinary metabolites; and studies in healthy volunteers.

1 reference

12 December 2020

Multiple forms of inducible drug-metabolizing enzymes: A reasonable mechanism by which any organism can cope with adversity

1 reference

12 December 2020

Polymorphic sulphoxidation of S-carboxymethyl-L-cysteine in man

1 reference

12 December 2020

Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquine

1 reference

12 December 2020

Metabolic demethylation of 3-methyl-5-ethyl-5-phenyl hydantoin (Mesantoin)

1 reference

12 December 2020

Pharmacogenetics of tolbutamide metabolism in humans

1 reference

12 December 2020

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

1 reference

12 December 2020

Spectral binding studies of the polymorphically metabolized drugs debrisoquine, sparteine and phenformin by cytochrome P-450 of normal and hydroxylation deficient rat strains

1 reference

12 December 2020

Inherited defects of hepatic drug metabolism

1 reference

12 December 2020

Polymorphic hydroxylation of Debrisoquine in man.

1 reference

12 December 2020

Deficient metabolism of debrisoquine and sparteine

1 reference

12 December 2020

Multiple forms of cytochrome P-450 and the importance of molecular biology and evolution

1 reference

12 December 2020

INSUFFICIENT PARAPHYDROXYLATION AS A CAUSE OF DIPHENYLHYDANTOIN TOXICITY

1 reference

12 December 2020

Multiplicity of mammalian microsomal cytochromes P-45

1 reference

12 December 2020

Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detection

1 reference

12 December 2020

Stereoselective metabolism, pharmacokinetics and biliary elimination of phenylethylhydantoin (Nirvanol) in the dog

1 reference

12 December 2020

A major pathway of mephenytoin metabolism in man. Aromatic hydroxylation to p-hydroxymephenytoin

1 reference

12 December 2020

Stereoselective metabolism of mephenytoin in man

1 reference

12 December 2020

Influence of DH/DL alleles regulating debrisoquine oxidation on phenytoin hydroxylation

1 reference

12 December 2020

Mephenytoin hydroxylation deficiency: kinetics after repeated doses

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00541938

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6489416%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1 reference